½ÃÀ庸°í¼­
»óǰÄÚµå
1541090

¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀå º¸°í¼­ : Á¦Ç°, ¼ö¼ú, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Motion Preservation Devices Market Report by Product, Surgery, End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 145 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 18¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 29¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̰í, ¿¹Ãø ±â°£ µ¿¾È 5.3%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

°¡µ¿¼º º¸Á¸ ±â±â´Â °íÁ¤¼úÀ» ÇÊ¿ä·Î ÇÏÁö ¾Ê´Â ôÃß ÁúȯÀÇ Ä¡·á¿¡ ÀÌ¿ëµË´Ï´Ù. ±â´ÉÀûÀΠôÃß ÀåÄ¡ÀÇ ¿òÁ÷ÀÓÀ» À¯ÁöÇϸ鼭 ¾ÈÁ¤È­¸¦ Á¦°øÇϰí ÅëÁõÀ» Á¦°ÅÇÕ´Ï´Ù. À̵éÀº ÁÖ·Î Ãß°£ÆÇ Àüü ġȯ¼ú(TDR), ÀΰøÇ٠ġȯ¼ú, ÈÄ¹æ µ¿Àû ÀåÄ¡, ÆÐ½Ë ġȯ¼ú·Î ±¸¼ºµÇ¸ç, °¢°¢ ´Ù¸¥ ¸ñÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ¿¹¸¦ µé¾î, Ãß°£ÆÇ Àüü ġȯ¼úÀº Ãß°£ÆÇÀÇ ¿ÏÀüÇÑ Á¦°Å¿¡ Àû¿ëµÇ¸ç, ÀΰøÇ٠ġȯ¼úÀº ȯÇü Àý°³¿¡ ÀÇÇØ ³ú¼öÇÙÀ» Á¦°ÅÇØ¾ß ÇÕ´Ï´Ù. ÇöÀç´Â À¶ÇÕÇü ¼ö¼úº¸´Ù ¿îµ¿¿ÂÁ¸Çü ±â¼ú·ÎÀÇ ½ÃÇÁÆ®°¡ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ±× °á°ú Çõ½ÅÀûÀÎ ¿îµ¿¿ÂÁ¸±â±¸ÀÇ °³¹ßÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

°¡µ¿¼º º¸Á¸ ±â±â ½ÃÀå µ¿Çâ

¿äÅë¿¡ ÀÇÇÑ ÅëÁõÀ̳ª ±â´É ÀúÇÏ¿¡ °í¹ÎÇϴ ȯÀÚÀÇ Ä¡·á ´ëü ¼ö´ÜÀ̳ª º¸Á¶ ¼ö´ÜÀ¸·Î¼­ ´Ù¾çÇÑ ¿îµ¿ ¿ÂÁ¸ ±â±¸°¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. À̰ÍÀº Èí¿¬, ºñ¸¸, ¾É±â ½¬¿î ¶óÀÌÇÁ ½ºÅ¸ÀÏ·Î ÀÎÇÑ Ã´Ãß ÁúȯÀÇ À¯º´·ü »ó½Â°ú ÇÔ²² ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇØ Ç㸮 ôÃß ÇùÂøÁõ, º¯¼º Ãß°£ÆÇÁõ, °ñ°üÀý¿°À¸·Î ÀÎÇÑ ¼Ò¸éü ÅëÁõ µîÀÇ Áõ»óÀ» Ä¡·áÇÏ´Â ¼ö¼ú °Ç¼ö°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À̰ÍÀº ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. À̿ʹ º°µµ·Î ´Ù¼öÀÇ ´ë±â¾÷µéÀÌ ¼±Áø±â¼úÀ» žÀçÇÑ Â÷¼¼´ë ÀåÄ¡¸¦ µµÀÔÇϰí ÀÖ¾î ½ÃÀå¿¡ ¹àÀº Àü¸ÁÀ» âÃâÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ÀÇ ÀÇ·á±â¾÷ÀÎ Aesculap, Inc.´Â ÀÎÅÚ¸®ÀüÆ® ¸ð¼Ç ±â¼úÀ» žÀçÇÑ activL ÀΰøÃß°£ÆÇÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ Àΰø Ãß°£ÆÇÀº º¯¼º Ãß°£ÆÇÁõ(DDD) ȯÀÚ¸¦À§ÇÑ 3 ¼¼´ëÀÇ ¿îµ¿ À¯Áö ÀåÄ¡À̸ç, °Ç°­ÇÑ Àΰ£ ôÃßÀÇ ÀÚ¿¬ »ýü ¸ÞÄ«´Ð°ú À¯»çÇϸç, ÀÎÁ¢ÇÑ ¼öÁØÀÇ ÇØºÎÇÐ Àû ±¸Á¶¿¡ ¹ÌÄ¡´Â ¿µÇâ Å©°Ô ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • 2023³â ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀå ±Ô¸ð´Â?
  • 2024-2032³â¿¡ À־ÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀå ¼ºÀå·üÀº?
  • ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâÀº?
  • ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀåÀÇ Á¦Ç°º° ³»¿ªÀº?
  • ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀåÀÇ ¼ö¼úº° ³»¿ªÀº?
  • ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀåÀÇ ÃÖÁ¾ »ç¿ëÀÚº° ³»¿ªÀº?
  • ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ °¡µ¿¼º º¸Á¸ ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • µ¿Àû ¾ÈÁ¤È­ ÀåÄ¡
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • °¡½Ãµ¹±â°£ ½ºÆäÀ̼­
      • ½Ã±Ã±Ù ½ºÅ©·ù º£À̽º ½Ã½ºÅÛ
      • ÆÐ½Ë ±³È¯ Á¦Ç°
    • ½ÃÀå ¿¹Ãø
  • Àΰø Ãß°£ÆÇ ġȯ ÀåÄ¡
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • Àΰø °æÃß Ãß°£ÆÇ
      • Àΰø ¿äÃß Ãß°£ÆÇ
    • ½ÃÀå ¿¹Ãø
  • À±»ó ¼öº¹ ÀåÄ¡
  • ÇÙÃß°£ÆÇ º¸Ã¶ ÀåÄ¡

Á¦7Àå ½ÃÀå ºÐ¼® : ¼ö¼úº°

  • ôÃß °³¹æ ¼ö¼ú
  • Àúħ½À ôÃß ¼ö¼ú

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • Á¤Çü¿Ü°ú Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Aurora Spine Inc
    • B. Braun Melsungen AG
    • Globus Medical
    • HPI Implants
    • Johnson & Johnson Private Limited
    • Medtronic
    • NuVasive Inc.
    • Orthofix Medical Inc
    • Surgalign
    • ulrich GmbH & Company KG
    • Zimmer Biomet
BJH 24.09.12

The global motion preservation devices market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032.

Motion preservation devices are utilized in the treatment of several spine conditions without fusion. They provide stabilization and eliminate pain while preserving the motion of the functional spinal unit. They mainly comprise total disc replacement (TDR), prosthetic nucleus replacement, posterior dynamic devices, and facet replacement, which are used for different purposes. For example, TDRs find application in the complete removal of the disc, while prosthetic nucleus replacements necessitate evacuation of the nucleus pulposus through an annulotomy. Nowadays, a shift towards motion-sparing technology over fusion-type procedures is resulting in the increasing development of innovative motion-preserving devices.

Motion Preservation Devices Market Trends:

A wide variety of motion preservation devices are used as treatment alternatives or adjuncts for patients suffering from pain and loss of function caused by back issues. This, in confluence with the rising prevalence of spine problems on account of smoking, obesity, and sedentary lifestyles, represents one of the major factors driving the market. In addition, the growing geriatric population is resulting in a significant increase in the number of surgeries utilized for treating symptoms of lumbar spinal stenosis, degenerative disc disease, and facet pain from osteoarthritis. This is positively influencing the demand for motion preservation devices across the globe. Apart from this, several leading companies are introducing next-generation devices with advanced technology, which is creating a positive outlook for the market. For instance, Aesculap, Inc., a US-based healthcare company, launched the activL artificial disc with intelligent motion technology. It is a third-generation motion preservation device for degenerative disc disease (DDD) patients, which resembles the natural biomechanics of the healthy human spine and significantly reduces the impact on adjacent level anatomy.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global motion preservation devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, surgery, and end user.

Breakup by Product:

Dynamic Stabilization Devices

Interspinous Process Spacers

Pedicle Screw-Based Systems

Facet Replacement Products

Artificial Discs Replacement Devices

Artificial Cervical Discs

Artificial Lumbar Discs

Annulus Repair Devices

Nuclear Disc Prostheses Devices

Breakup by Surgery:

Open Spine Surgery

Minimally Invasive Spine Surgery

Breakup by End User:

Hospitals

Orthopedic Clinics

Ambulatory Surgical Centers (ASCs)

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aurora Spine Inc, B. Braun Melsungen AG, Globus Medical, HPI Implants, Johnson & Johnson Private Limited, Medtronic, NuVasive Inc., Orthofix Medical Inc, Surgalign, ulrich GmbH & Company KG, and Zimmer Biomet.

Key Questions Answered in This Report

  • 1. What was the size of the global motion preservation devices market in 2023?
  • 2. What is the expected growth rate of the global motion preservation devices market during 2024-2032?
  • 3. What are the key factors driving the global motion preservation devices market?
  • 4. What has been the impact of COVID-19 on the global motion preservation devices market?
  • 5. What is the breakup of the global motion preservation devices market based on the product?
  • 6. What is the breakup of the global motion preservation devices market based on the surgery?
  • 7. What is the breakup of the global motion preservation devices market based on the end user?
  • 8. What are the key regions in the global motion preservation devices market?
  • 9. Who are the key players/companies in the global motion preservation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Motion Preservation Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Dynamic Stabilization Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Interspinous Process Spacers
      • 6.1.2.2 Pedicle Screw-Based Systems
      • 6.1.2.3 Facet Replacement Products
    • 6.1.3 Market Forecast
  • 6.2 Artificial Discs Replacement Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Artificial Cervical Discs
      • 6.2.2.2 Artificial Lumbar Discs
    • 6.2.3 Market Forecast
  • 6.3 Annulus Repair Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Nuclear Disc Prostheses Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Surgery

  • 7.1 Open Spine Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Minimally Invasive Spine Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Orthopedic Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centers (ASCs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aurora Spine Inc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Globus Medical
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 HPI Implants
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Johnson & Johnson Private Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Medtronic
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 NuVasive Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Orthofix Medical Inc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Surgalign
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 ulrich GmbH & Company KG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Zimmer Biomet
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦